論文・技術情報追加のお知らせ

①Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022.

心筋炎を例とした、COVID-19ワクチンの安全性評価研究

対象DB：VAERS

②Mining and analysis of adverse drug reactions associated with perampanel based on FAERS database.

ペランパネルの安全性評価研究

対象DB：FAERS

③Optic Neuritis After COVID-19 Vaccination: An Analysis of the Vaccine Adverse Event Reporting System.

COVID-19ワクチン接種後における視神経炎の関連性調査研究

対象DB：VAERS

④Clarifying the grey space of sugammadex induced bradycardia.

スガマデクスによる徐脈の発生リスク調査研究

対象DB：FAERS

⑤Post-Marketing Safety Concerns with Upadacitinib: A Disproportionality Analysis of the FDA Adverse Event Reporting system.

ウパダシチニブに関連する有害事象評価研究

対象DB：FAERS

⑥The use and safety risk of repurposed drugs for COVID-19 patients: lessons learned utilizing the Food and Drug Administration's Adverse Event Reporting System.

ヒドロキシクロロキンおよびレムデシビルに関連する副作用の評価研究

対象DB：FAERS

⑦Analysis of clozapine-induced seizures using the Japanese Adverse Drug Event Report database.

クロザピンによる痙攣発症傾向の調査、解析研究

対象DB：JADER